Quidel and World Champion Los Angeles Rams Partner to Fight COVID-19 and Promote Health Awareness in the LA Community

SAN DIEGO–(BUSINESS WIRE). announced a multi-year partnership agreement to promote health awareness and COVID-19 testing. The agreement makes Quidel an “official affiliate of the Los Angeles Rams” and designates Quidel’s QuickVue rapid at-home antigen test as the “official at-home COVID test of the Los Angeles Rams.” In addition, the partnership includes a variety of promotions and stadium activation initiatives, as well as a presence on community programs in the greater Los Angeles area.

“As a leading diagnostics company founded and headquartered in Southern California, Quidel is proud to be an official partner of the Los Angeles Rams,” said Douglas Bryant, chairman and CEO of QuidelOrtho. “It is an honor to work close to home and with a successful organization whose commitment to community service matches our own. We look forward to working together to promote health awareness and the benefits of COVID-19 testing.”

“As we prepare to start our season and defend our championship, we are excited to welcome Quidel to the Rams family,” said Jen Prince, Rams chief commercial officer. “Quidel’s history in Southern California and commitment to health and wellness make her a great choice to enhance game days and our community events throughout the year.”

Mr. Bryant noted, “With our rapid 10-minute QuickVue antigen test, to be marketed as the ‘Official Los Angeles Rams At-Home COVID Test,’ we will work with the Rams organization to spread the message of simple and accessible to represent – conducting COVID-19 home testing at the stadium and communicating the importance of testing across Rams radio, television and digital programs to all communities.”

About QuidelOrtho Corporation

QuidelOrtho Corporation (Nasdaq: QDEL) brings together the power of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission to develop and manufacture innovative technologies that enhance the performance of diagnostic tests and create better patient outcomes across the healthcare continuum.

As one of the world’s largest providers of in vitro diagnostics (IVD) with more than 120 years of collective experience, we combine industry-leading expertise in immunoassays and molecular testing with a global presence in clinical laboratories and in transfusion medicine.

Our company’s comprehensive product portfolio provides accuracy, speed, automation and access, delivering critical information when and where it is needed most. Inspired by a spirit of service, the QuidelOrtho family is committed to improving the well-being of people worldwide and is happy in the knowledge that we are making a difference. Visit www.quidelortho.com for more information.